News

The company is expected to initiate a Phase I trial with mibefradil in normal healthy volunteers on 2 March 2012. The company will also initiate Phase Ib trial

In January 2011, Dompé has acquired 49% stake in Anabasis and also patent rights for the use of NGF to treat neurotrophic keratitis (NK). Dompé will become the

KDIL is a contract manufacturer of sterile injectables in India, as well as certain assets of NBZ Pharma. Akorn is a pharmaceutical company engaged in the development, manufacture

NanoSonic’s Trappsol Cyclo is FDA and EMEA designated orphan drug for the treatment of Niemann Pick Type-C disease, also known as Childhood Alzheimer’s. Trappsol Cyclo is currently being

Acetadote (acetylcysteine) is injectable drug used to treat acetaminophen overdose, and Caldolor (ibuprofen) Injection is used to treat pain and fever in the hospital setting. According to the

As per the new agreement, Impax will implement the Flex platform, which will drive the expansion of Revitas solutions across the enterprise from the generics division to the

The suite includes electronic data capture (EDC) and data management, interactive response technology (IRT/IVR/IWR), and clinical trial management (CTMS) solutions. The Phase IIIb cardiology study is planned to

The 340B drug discount program is a Federal Public Health Service Program that allows qualified health centers and hospitals to buy drugs for less than half the cost

The new services include sample aliquoting, nucleic acid extraction and verification and PBMC (Peripheral Blood Mononuclear Cells) processing. With the new services, the company can provide a sample